title: Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?
authors.forename: Masakazu
authors.initials: M
authors.lastname: Haneda
authors.forename: Akizuki
authors.initials: A
authors.lastname: Morikawa
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000145:classification / Q000150:complications* / Q000188:drug therapy*
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin